Cargando…
T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis
The use of immune checkpoint inhibitors (ICIs) targeting the T cell inhibitory pathways has revolutionized cancer treatment. However, ICIs might induce progressive atopic dermatitis (AD) by affecting T cell reactivation. The critical role of T cells in AD pathogenesis is widely known. T cell co-sign...
Autores principales: | Zheng, Chunjiao, Shi, Yuling, Zou, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040887/ https://www.ncbi.nlm.nih.gov/pubmed/36993982 http://dx.doi.org/10.3389/fimmu.2023.1081999 |
Ejemplares similares
-
Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases
por: He, Weiwei, et al.
Publicado: (2019) -
The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease
por: Kumar, Sandeep, et al.
Publicado: (2018) -
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
por: Chester, Cariad, et al.
Publicado: (2015) -
Autoimmunity (or Not) in Atopic Dermatitis
por: Roesner, Lennart M., et al.
Publicado: (2019) -
Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules
por: Rapoport, Bernardo L., et al.
Publicado: (2022)